The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s systemic lupus erythematosus treatment market report forecasts the systemic lupus erythematosus treatment market size to grow to $3.98 Billion by 2027, with a CAGR (compound annual growth rate) of more than 9%.

Learn More On The Systemic Lupus Erythematosus Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/systemic-lupus-erythematosus-treatment-global-market-report

Systemic Lupus Erythematosus Treatment Market Size Forecast
The global systemic lupus erythematosus treatment market is expected to grow from $2.50 billion in 2023 to $2.74 billion in 2023 at a compound annual growth rate (CAGR) of 9.54%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global systemic lupus erythematosus treatment market size is expected to reach $3.98 billion in 2027 at a CAGR of 9.84%.

North America held the largest systemic lupus erythematosus treatment market share.

Key Systemic Lupus Erythematosus Treatment Market Driver ­– Rise In Number Of Autoimmune Disorders
According to a report shared by the American Autoimmune Related Diseases Association (AARDA), a US-based nonprofit organisation dedicated to autoimmune awareness, as many as 50 million Americans were estimated to have an autoimmune disease in June 2020, costing $86 billion per year. According to an article provided by the City, University of London, a UK-based public research university, 4 million people in the UK, or 7% of the population, are expected to have at least one autoimmune illness in October 2021. Over 80 autoimmune disorders have been identified, and their prevalence is increasing by 3-9% per year. As a result, the growing number of autoimmune conditions is propelling the systemic lupus erythematosus therapy market forward.

Request for A Sample Of The Global Systemic Lupus Erythematosus Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9163&type=smp

Key Systemic Lupus Erythematosus Treatment Market Trend – Introducing Improved Biologic Agents
A biologic agent is a material derived from a live organism or its products that is used to prevent, diagnose, or treat cancer and other disorders. Major market players are working on the development of biologic agents that will be used to treat systemic lupus erythematosus in various age groups. For example, GlaxoSmithKline plc, a UK-based pharmaceutical and biotechnology firm, announced in December 2020 that the US Food and Drug Administration (FDA) has approved BENLYSTA (belimumab) for the treatment of adult patients with active lupus nephritis (LN). Lupus nephritis, an inflammation of the kidneys, is caused by systemic lupus erythematosus (SLE). Benlysta is a medication that is used to treat both SLE and LN. This approval also includes SLE and LN formulations in both intravenous and subcutaneous forms.

Systemic Lupus Erythematosus Treatment Market Segment
1) By Drug: Antimalarial Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Corticosteroids, Immunosuppressive Drugs
2) By Route Of Administration: Sub-Cutaneous, Oral, Intravenous
3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Sales

Systemic Lupus Erythematosus Treatment Market Major Players and Strategies
Major players in the systemic lupus erythematosus treatment market are GlaxoSmithKline PLC, Aurinia Pharmaceuticals, Pfizer, Merck & Co, Anthera Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb Company, Inc., F. Hoffmann-La Roche Ltd., ImmuPharma PLC, Sanofi, Eli Lilly, Amgen, Inc., Johnson & Johnson Services, Inc., Lycera Corporation and Mylan NV.

Merck, a US-based pharmaceutical corporation, paid $1.85 billion for Pandion Therapeutics in March 2021. Merck obtained the TALON technology from Pandion Therapeutics through this acquisition, which will address unmet needs in autoimmune disorders by rebalancing the immune response. Pandion therapies is a biotechnology business established in the United States that focuses on the development of innovative therapies. PT101, the company’s flagship candidate, is a designed IL-2 mutein with a protein backbone. PT101 works by activating and increasing Tregs to treat autoimmune illnesses like ulcerative colitis and systemic lupus erythematosus.

The Systemic Lupus Erythematosus Treatment Global Market Report 2023 covers regional data on systemic lupus erythematosus treatment market size, systemic lupus erythematosus treatment market trends and drivers, opportunities, strategies, and systemic lupus erythematosus treatment market competitor analysis. The countries covered in the systemic lupus erythematosus treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Systemic lupus erythematosus is an autoimmune illness in which the immune system attacks its own tissues, resulting in extensive inflammation and tissue destruction in the affected organs. It causes problems with the joints, skin, brain, lungs, kidneys, and blood vessels. It is the most prevalent variety of lupus and cannot be cured, but it can be controlled with medicinal interventions and lifestyle adjustments. The majority of systemic lupus erythematosus treatment comprises of immunosuppressive medications that suppress the immune system’s activities.

View More Reports Related To The Systemic Lupus Erythematosus Treatment Market –
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2023
Polycystic Ovarian Syndrome Treatment Global Market Report 2023
Alzheimer Disease Treatment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: